KRISTIN CLEMENS: Open Payments
NPI 1154961381 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,923 in 94 payments from 15 companies in 2025. Trend: 2023 $4,307 · 2024 $11,870 · 2025 $15,923
Speaker / faculty: $11,000Travel & lodging: $2,663Food & beverage: $1,580Consulting: $680
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $14,171 |
| Janssen Scientific Affairs, LLC | 1 | $680 |
| Otsuka America Pharmaceutical, Inc. | 12 | $265 |
| Axsome Therapeutics, Inc. | 10 | $216 |
| Lundbeck LLC | 5 | $122 |
| ACADIA Pharmaceuticals Inc | 1 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Alkermes, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
Products named: VRAYLAR, SPRAVATO, Auvelity, REXULTI, ABILIFY MAINTENA, NUPLAZID, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across MD — which companies pay providers there.
